RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Enzychem Lifesciences Stock

Enzychem Lifesciences Debt 2024

Enzychem Lifesciences Debt

0 KRW

Ticker

183490.KQ

ISIN

KR7183490002

In 2024, Enzychem Lifesciences's total debt was 0 KRW, a -100% change from the 30,095.76 KRW total debt recorded in the previous year.

Enzychem Lifesciences Aktienanalyse

What does Enzychem Lifesciences do?

Enzychem Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Enzychem Lifesciences's Debt Structure

Enzychem Lifesciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Enzychem Lifesciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Enzychem Lifesciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Enzychem Lifesciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Enzychem Lifesciences stock

What is the debt of Enzychem Lifesciences this year?

Enzychem Lifesciences has a debt level of 0 KRW this year.

What was the debt of Enzychem Lifesciences compared to the previous year?

The debt of Enzychem Lifesciences has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Enzychem Lifesciences?

High debt can pose a risk for investors of Enzychem Lifesciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Enzychem Lifesciences?

Low debt means that Enzychem Lifesciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Enzychem Lifesciences affect the company?

An increase in debt of Enzychem Lifesciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Enzychem Lifesciences affect the company?

A reduction in debt of Enzychem Lifesciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Enzychem Lifesciences?

Some factors that can influence the debt of Enzychem Lifesciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Enzychem Lifesciences so important for investors?

The debts of Enzychem Lifesciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Enzychem Lifesciences take to change the debt?

To change the debt, Enzychem Lifesciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Enzychem Lifesciences pay?

Over the past 12 months, Enzychem Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enzychem Lifesciences is expected to pay a dividend of 0 KRW.

What is the dividend yield of Enzychem Lifesciences?

The current dividend yield of Enzychem Lifesciences is .

When does Enzychem Lifesciences pay dividends?

Enzychem Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enzychem Lifesciences?

Enzychem Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Enzychem Lifesciences?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enzychem Lifesciences located?

Enzychem Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enzychem Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enzychem Lifesciences from 12/16/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 12/16/2024.

When did Enzychem Lifesciences pay the last dividend?

The last dividend was paid out on 12/16/2024.

What was the dividend of Enzychem Lifesciences in the year 2023?

In the year 2023, Enzychem Lifesciences distributed 0 KRW as dividends.

In which currency does Enzychem Lifesciences pay out the dividend?

The dividends of Enzychem Lifesciences are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enzychem Lifesciences

Our stock analysis for Enzychem Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enzychem Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.